Baogang Xie

940 total citations
48 papers, 744 citations indexed

About

Baogang Xie is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Baogang Xie has authored 48 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Baogang Xie's work include Metabolomics and Mass Spectrometry Studies (9 papers), Liver Disease Diagnosis and Treatment (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Baogang Xie is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), Liver Disease Diagnosis and Treatment (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Baogang Xie collaborates with scholars based in China, United States and Australia. Baogang Xie's co-authors include Michael J. Waters, Horst Joachim Schirra, Haijun Zhong, Zhirong Zhang, Tao Gong, Wenlong Yang, Shouhua Zhang, Aihong Liu, Jie Liu and Xuan Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Food Chemistry.

In The Last Decade

Baogang Xie

46 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baogang Xie China 14 366 114 102 99 91 48 744
Guru R. Valicherla India 19 220 0.6× 112 1.0× 62 0.6× 76 0.8× 68 0.7× 32 662
Dan He China 20 410 1.1× 123 1.1× 76 0.7× 116 1.2× 98 1.1× 70 1.0k
Chun Tao China 18 311 0.8× 117 1.0× 63 0.6× 58 0.6× 67 0.7× 36 812
Athar Husain India 16 364 1.0× 62 0.5× 78 0.8× 45 0.5× 38 0.4× 37 750
Xiaohui Wei China 16 580 1.6× 72 0.6× 84 0.8× 139 1.4× 60 0.7× 42 1.2k
Lulu Wang China 15 266 0.7× 118 1.0× 55 0.5× 27 0.3× 57 0.6× 44 656
Santwana Padhi India 10 305 0.8× 131 1.1× 50 0.5× 49 0.5× 156 1.7× 15 843
Alaa Sirwi Saudi Arabia 18 244 0.7× 85 0.7× 83 0.8× 38 0.4× 33 0.4× 34 682
Thikryat Neamatallah Saudi Arabia 18 301 0.8× 36 0.3× 65 0.6× 47 0.5× 46 0.5× 41 865
Bikash Manandhar Australia 17 417 1.1× 29 0.3× 92 0.9× 71 0.7× 92 1.0× 35 1.0k

Countries citing papers authored by Baogang Xie

Since Specialization
Citations

This map shows the geographic impact of Baogang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baogang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baogang Xie more than expected).

Fields of papers citing papers by Baogang Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baogang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baogang Xie. The network helps show where Baogang Xie may publish in the future.

Co-authorship network of co-authors of Baogang Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Baogang Xie. A scholar is included among the top collaborators of Baogang Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baogang Xie. Baogang Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Yuanwang, et al.. (2025). Estimating heart rate variability parameters in long-term rPPG signals using spatiotemporal attention mechanisms. Biomedical Signal Processing and Control. 112. 108407–108407.
2.
Cai, Hong-Xin, Yu Zhang, Jingyu Wang, et al.. (2024). D-glucaro-1,4-lactone improves Diethylnitrosamine induced hepatocellular carcinoma in rats via the uric acid-ROS pathway. Journal of Ethnopharmacology. 334. 118569–118569. 4 indexed citations
3.
Cai, Hong-Xin, Xiaoyue Du, Lele Wang, et al.. (2024). Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats. Bioanalysis. 16(10). 461–473. 2 indexed citations
4.
Wu, Zhiguo, Fang Qiu, Di Jin, et al.. (2023). The hepatoprotective effect of aspirin on carbon tetrachloride‑induced hepatic fibrosis via inhibition of TGFβ‑1 pathway and pro‑inflammatory cytokines IL‑1β and COX‑2 in rats. Experimental and Therapeutic Medicine. 25(5). 232–232. 3 indexed citations
5.
Xiao, Juhua, Ling Huang, Xue Li, et al.. (2023). Roxadustat induces hepatotoxicity in zebrafish embryos via inhibiting Notch signaling. Journal of Applied Toxicology. 43(7). 1073–1082. 3 indexed citations
7.
Xie, Qiong, Lan Yu, Zhiguo Wu, et al.. (2023). Effect of Artificial Liver Support Systems on Gut Microbiota in Patients with HBV-Related Acute-on-Chronic Liver Failure. Pathogens. 12(9). 1094–1094. 2 indexed citations
8.
Jin, Nan, Mengjie Yu, Xiaoyue Du, et al.. (2023). Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics. BMC Cardiovascular Disorders. 23(1). 167–167. 7 indexed citations
9.
Yu, Mengjie, Yuanwang Wei, Qiong Wang, et al.. (2023). Amino acids analysis reveals serum methionine contributes to diagnosis of the Kawasaki disease in mice and children. Journal of Pharmaceutical and Biomedical Analysis. 239. 115873–115873.
10.
Zhou, Qingqing, et al.. (2023). Hosimosines A-E, structurally diverse cytisine derivatives from the seeds of Ormosia hosiei Hemsl. et Wils. Fitoterapia. 170. 105661–105661. 2 indexed citations
11.
Jiang, Junhao, et al.. (2022). Effects of Astragaloside IV on the Pharmacokinetics of Metoprolol in Rats and itsMechanism. Current Drug Metabolism. 23(2). 131–136. 7 indexed citations
12.
Zhang, Yu, Jing Yang, Jiayi Wang, et al.. (2019). Quantification of Serum Purine Metabolites for Distinguishing Patients with Hepatitis B from Hepatocellular Carcinoma. Bioanalysis. 11(10). 1003–1013. 11 indexed citations
13.
Yang, Wenlong, et al.. (2018). Alterations of glutamine and glutamate levels in patients and rats with hepatocellular carcinoma. Journal of Liquid Chromatography & Related Technologies. 41(10). 588–594. 1 indexed citations
14.
Yu, Mengjie, et al.. (2018). Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics. Journal of Proteome Research. 17(10). 3517–3525. 26 indexed citations
15.
Wang, Haipeng, et al.. (2017). Improved Oral Bioavailability and Liver Targeting of Sorafenib Solid Lipid Nanoparticles in Rats. AAPS PharmSciTech. 19(2). 761–768. 29 indexed citations
16.
Xie, Baogang, et al.. (2015). Reduction of urinary uric acid excretion in patients with proteinuria. Journal of Chromatography B. 1006. 59–64. 10 indexed citations
17.
Xie, Baogang, et al.. (2015). Enhanced Estrogenic Activity of Soybean Isoflavones by Coadministration of Liuwei Dihuang Pills in Ovariectomized Rats. Phytotherapy Research. 29(7). 1054–1061. 8 indexed citations
18.
Xie, Baogang, et al.. (2015). Increased Intestinal Absorption of Genistein by Coadministering Verapamil in Rats. European Journal of Drug Metabolism and Pharmacokinetics. 41(5). 637–643. 2 indexed citations
19.
Xie, Baogang, Michael J. Waters, & Horst Joachim Schirra. (2012). Investigating Potential Mechanisms of Obesity by Metabolomics. SHILAP Revista de lepidopterología. 2012. 1–10. 114 indexed citations
20.
Xie, Baogang, Huifang Huang, Jian‐Dong Huang, Naisheng Chen, & Jinling Huang. (2004). [Determination and pharmacokinetics of photosensitizer ZnPcS2P2 uptaken by K562 cells].. PubMed. 24(11). 1415–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026